Chase Leavitt was Appointed as General Counsel and Corporate Secretary at BioTime

Date of management change: May 22, 2019 

What Happened?

Alameda, -based BioTime Appointed Chase Leavitt as General Counsel and Corporate Secretary

 

About the Company

BioTime is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. BioTime`s pipeline is based on two platform technologies which encompass cell replacement and cell/drug delivery. BioTime`s lead cell replacement product candidate is OpRegen®, a retinal pigment epithelium transplant therapy in Phase 2 development for the treatment of dry age-related macular degeneration, the leading cause of blindness in the developed world. BioTime common stock is traded on the NYSE American and TASE under the symbol BTX.

 

About the Person

Chase Leavitt is General Counsel and Corporate Secretary at BioTime. Previously, Chase held various senior legal leadership roles in the industry.

 

Info Source

News

 
 

Other IT executives who recently changed jobs as well: Heen Mary, Kolar Sarah, Beasley John, Bennett Kate, Porter Samuel, Milanesio Nicoletta, Lowen Cara, Kunz Betsy, Stevens Greg, Klauder Jeffrey, McCabe Thomas

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.